通畅腰动脉对腹主动脉瘤腔内修复术后伴II型内漏的瘤囊扩大的影响
该单中心回顾性队列研究纳入2006年1月至2019年12月间336例腹主动脉瘤腔内修复术(EVAR)患者,按术前肠系膜下动脉(IMA)是否通畅及通畅腰动脉数量(高≥4条 vs 低≤3条)分为四组。中位随访65.1个月,结果显示术前IMA通畅时,高数量通畅腰动脉组无瘤囊扩大率显著低于低数量组(EVAR后5年69.0% vs 81.7%,p < .001);而术前IMA闭塞时两组无显著差异(95.0% vs 100%,p = .075)。
要点
- 术前IMA通畅且通畅腰动脉≥4条者,EVAR后5年无瘤囊扩大率69.0%,低于通畅腰动脉≤3条者的81.7%(p < .001)。
- 术前IMA闭塞且通畅腰动脉≥4条者,EVAR后5年无瘤囊扩大率95.0%,与≤3条者的100%无显著差异(p = .075)。
- 出院时整体II型内漏发生率:IMA通畅高腰动脉组59.7% vs 低腰动脉组36.5%(p < .001);IMA闭塞高腰动脉组33.3% vs 低腰动脉组4.8%(p < .001)。
核心结论
- 术前IMA通畅时,高数量通畅腰动脉似乎在伴T2EL的瘤囊扩大中起重要作用;而术前IMA闭塞时,高数量通畅腰动脉对瘤囊扩大的影响似乎有限。
研究设计与样本
- 单中心回顾性队列注册研究,2006年1月至2019年12月间共回顾336例使用市售器械的EVAR,排除随访≥12个月期间的I型或III型内漏。
- 按术前IMA是否通畅及通畅腰动脉数量高(≥4条)或低(≤3条)分为四组:第1组IMA通畅且高数量通畅腰动脉,第2组IMA通畅且低数量通畅腰动脉,第3组IMA闭塞且高数量通畅腰动脉,第4组IMA闭塞且低数量通畅腰动脉。
- 第1、2、3、4组分别纳入124、104、45、63例患者,中位随访时长65.1个月。
主要发现
- 出院时整体II型内漏(T2EL)发生率在第1组与第2组间差异显著(59.7% vs 36.5%,p < .001),第3组与第4组间亦差异显著(33.3% vs 4.8%,p < .001)。
- 术前IMA通畅患者中,第1组无瘤囊扩大率显著低于第2组(EVAR后5年69.0% vs 81.7%,p < .001)。
- 术前IMA闭塞患者中,第3组与第4组无瘤囊扩大率无显著差异(EVAR后5年95.0% vs 100%,p = .075)。
关键数值与推荐
- 通畅腰动脉数量分组阈值:高为≥4条,低为≤3条。
- 随访时长要求:≥12个月;中位随访时长65.1个月。
- 第1组与第2组出院时T2EL发生率59.7% vs 36.5%(p < .001);第3组与第4组33.3% vs 4.8%(p < .001)。
- 第1组与第2组EVAR后5年无瘤囊扩大率69.0% vs 81.7%(p < .001);第3组与第4组95.0% vs 100%(p = .075)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: This study aimed to investigate the impact of the number of patent lumbar arteries (LAs) on sac enlargement after endovascular aneurysm repair (EVAR). METHODS: This was a retrospective cohort single centre registry study. Between January 2006 and December 2019, 336 EVARs were reviewed using a commercially available device excluding type I or type III endoleaks during a follow up of ≥ 12 months. Patients were divided into four groups based on the pre-operative patency of the inferior mesenteric artery (IMA) and high (≥ 4) or low (≤ 3) number of patent LAs: Group 1, patent IMA and high number of patent LAs; Group 2, patent IMA and low number of patent LAs; Group 3, occluded IMA and a high number of patent LAs; Group 4, occluded IMA and low number of patent LAs. RESULTS: Groups 1, 2, 3, and 4 included 124, 104, 45, and 63 patients, respectively. The median follow up duration was 65.1 months. Significant differences in the incidence of overall type II endoleak (T2EL) at discharge between Group 1 and Group 2 (59.7% vs. 36.5%, p < .001) and between Group 3 and Group 4 (33.3% vs. 4.8%, p < .001) were observed. In patients with a pre-operatively patent IMA, the rate of freedom from aneurysm sac enlargement was significantly lower in Group 1 than in Group 2 (69.0% vs. 81.7% five years after EVAR, p < .001). In patients with a pre-operatively occluded IMA, the freedom rate from aneurysm sac enlargement was not significantly different between Groups 3 and Group 4 (95.0% vs. 100% five years after EVAR, p = .075). CONCLUSION: A high number of patent LAs seemed to have a significant role in sac enlargement with T2EL when the IMA was patent pre-operatively, whereas a high number of patent LAs seemed to have limited influence on sac enlargement when the IMA was occluded pre-operatively.
引用
- Ide T, Shimamura K, Shijo T, et al. Impact of Patent Lumbar Arteries on Aneurysm Sac Enlargement with Type II Endoleak after Endovascular Aneurysm Repair. Eur J Vasc Endovasc Surg. 2023. PMID: 37330200. doi:10.1016/j.ejvs.2023.06.003
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。